Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
42
KRMD Quote, Financials, Valuation and Earnings
Last price:
$4.85
Seasonality move
:
5.19%
Day range:
$4.63 - $4.96
52-week range:
$1.86 - $6.61
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.72x
P/B ratio:
13.65x
Volume:
118.1K
Avg. volume:
227.8K
1-year change:
52.04%
Market cap:
$224.7M
Revenue:
$33.6M
EPS (TTM):
-$0.08
Analysts' Opinion
-
Consensus RatingKORU Medical Systems, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 4 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $6.60, KORU Medical Systems, Inc. has an estimated upside of 36.08% from its current price of $4.85.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $5.00 representing 100% downside risk from its current price of $4.85.
Fair Value
-
According to the consensus of 5 analysts, KORU Medical Systems, Inc. has 36.08% upside to fair value with a price target of $6.60 per share.
KRMD vs. S&P 500
-
Over the past 5 trading days, KORU Medical Systems, Inc. has underperformed the S&P 500 by -1.29% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
KORU Medical Systems, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
KORU Medical Systems, Inc. has grown year-over-year revenues for 7 quarters straight. In the most recent quarter KORU Medical Systems, Inc. reported revenues of $10.4M.
Earnings Growth
-
KORU Medical Systems, Inc. has grown year-over-year earnings for 4 quarters straight. In the most recent quarter KORU Medical Systems, Inc. reported earnings per share of -$0.02.
Enterprise value:
219.9M
EV / Invested capital:
--
Price / LTM sales:
5.72x
EV / EBIT:
--
EV / Revenue:
5.63x
PEG ratio (5yr expected):
-0.28x
EV / Free cash flow:
-1,231.10x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$23.5M
Return On Assets:
-13.68%
Net Income Margin (TTM):
-9.5%
Return On Equity:
-22.13%
Return On Invested Capital:
-18.02%
Operating Margin:
-8.34%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $28.7M | $32M | $39.1M | $8.2M | $10.4M | |
| Gross Profit | $15.6M | $19.2M | $23.5M | $5M | $6.1M | |
| Operating Income | -$10.6M | -$7.1M | -$4M | -$1.7M | -$867.7K | |
| EBITDA | -$9.8M | -$6.1M | -$3.2M | -$1.5M | -$663.2K | |
| Diluted EPS | -$0.18 | -$0.26 | -$0.08 | -$0.03 | -$0.02 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $37.7M | $30.7M | $21.7M | $18.9M | $19.4M | |
| Total Assets | $41.4M | $42.7M | $35.4M | $27.4M | $27.1M | |
| Current Liabilities | $4.6M | $6.2M | $4.2M | $6.3M | $7.8M | |
| Total Liabilities | $4.6M | $10.2M | $7.9M | $9.7M | $10.6M | |
| Total Equity | $36.8M | $32.5M | $27.4M | $17.7M | $16.5M | |
| Total Debt | $804.8K | $4.1M | $3.8M | $3.4M | $2.9M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$4.7M | -$162.5K | $307.3K | -$923.9K | $65.5K | |
| Cash From Investing | -$830.1K | -$1.6M | -$477.4K | -$1.1M | -$52.5K | |
| Cash From Financing | -$186.1K | -$211.2K | -$172.2K | $374.5K | $396.3K | |
| Free Cash Flow | -$5.5M | -$1.8M | -$178.6K | -$2M | $13K | |
KRMD
Sector
Market Cap
$224.7M
$25.3M
Price % of 52-Week High
73.4%
49.41%
Dividend Yield
0%
0%
Shareholder Yield
-0.02%
-1.6%
1-Year Price Total Return
52.04%
-17.71%
Beta (5-Year)
0.469
0.490
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$4.84
200-day SMA
Buy
Level
$4.30
Bollinger Bands (100)
Sell
Level
4.26 - 5.76
Chaikin Money Flow
Sell
Level
-721.4K
20-day SMA
Buy
Level
$4.77
Relative Strength Index (RSI14)
Sell
Level
45.75
ADX Line
Sell
Level
32.52
Williams %R
Neutral
Level
-33.2062
50-day SMA
Sell
Level
$5.36
MACD (12, 26)
Buy
Level
0.66
25-day Aroon Oscillator
Sell
Level
-32
On Balance Volume
Sell
Level
-1.9M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (8.6121)
Sell
CA Score
(Annual)
Level (-0.3191)
Buy
Beneish M-Score
(Annual)
Level (-2.6326)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (2.97)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
KORU Medical Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. Its product portfolio includes FREEDOM60, FreedomEdge syringe drivers, Precision Flow Rate Tubing, and HIgH-Flo Subcutaneous Safety Needle Sets. The company was founded by Andrew I. Sealfon and Adrian W. Zorgniotti on March 24, 1980 and is headquartered in Mahwah, NJ.
Stock Forecast FAQ
In the current month, KRMD has received 4 Buy ratings 1 Hold ratings, and 0 Sell ratings. The KRMD average analyst price target in the past 3 months is $6.60.
-
Where Will KORU Medical Systems, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that KORU Medical Systems, Inc. share price will rise to $6.60 per share over the next 12 months.
-
What Do Analysts Say About KORU Medical Systems, Inc.?
Analysts are divided on their view about KORU Medical Systems, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that KORU Medical Systems, Inc. is a Sell and believe this share price will drop from its current level to $5.00.
-
What Is KORU Medical Systems, Inc.'s Price Target?
The price target for KORU Medical Systems, Inc. over the next 1-year time period is forecast to be $6.60 according to 5 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is KRMD A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for KORU Medical Systems, Inc. is a Buy. 4 of 5 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of KRMD?
You can purchase shares of KORU Medical Systems, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase KORU Medical Systems, Inc. shares.
-
What Is The KORU Medical Systems, Inc. Share Price Today?
KORU Medical Systems, Inc. was last trading at $4.85 per share. This represents the most recent stock quote for KORU Medical Systems, Inc.. Yesterday, KORU Medical Systems, Inc. closed at $4.85 per share.
-
How To Buy KORU Medical Systems, Inc. Stock Online?
In order to purchase KORU Medical Systems, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get KRMD Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
KRMD
Sector
P/E ratio
--
22.85x
PEG ratio
-0.28x
-0.01x
P/B ratio
13.65x
1.78x
Price / LTM sales
5.72x
1.52x
Growth Metrics
KRMD
Sector
Revenue growth
27.17%
3.33%
Earnings growth
51.3%
11.64%
Revenue (5-year growth)
7.75%
6.41%
Earnings forecast
-$0.01
-$0.20
Profitability
KRMD
Sector
Profitability FY 2024
$20.4M
$2.3M
Return on invested capital
-18.02%
-33.31%
Return on assets
-13.68%
-29.79%
Return on equity
-22.13%
-38.98%
Earnings Date
Last Earnings Date
Nov
12
Next Earnings Date
Mar
12
Estimated Next Earnings Date
Feb
11
Balance Sheet
KRMD
Sector
Total cash
$8.5M
$24.1M
Short term investments
--
$23.8M
Total assets
$28.5M
$70.1M
Long term debt
$2.9M
$2.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
49
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 37x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
42
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Sell
48
ZD alert for Mar 5
Ziff Davis, Inc. [ZD] is up 3.64% over the past day.
Sell
36
PSIX alert for Mar 5
Power Solutions International, Inc. [PSIX] is down 1.4% over the past day.
Buy
54
TREE alert for Mar 5
LendingTree, Inc. [TREE] is up 1.11% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
